National Meeting Highlights PAINWeek 2013

Please Log In or Register to continue.

Release Date: October 15, 2013
Expiration Date: October 15, 2014

Expected time to complete this activity as designed: 60 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

This educational initiative offers highlights from key sessions and posters presented at PAINWeek in 2013. Experts in the field of pain management and addiction medicine will offer clinical perspectives on the challenges of managing chronic pain.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, nurses, and other health care professionals who have an interest in enhancing their clinical skills in pain management.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify and interpret therapeutic implications of new data presented at the PAINWeek national conference related to safe and effective management of chronic pain patients
  • Translate current guidelines regarding safety and efficacy of current and novel approaches to chronic pain


Critical Documentation Skills – Jennifer Bolen, JD

Drug Diversion vs Pain Management: Finding a Balance − Commander John Burke

When Does Acute Pain Become Chronic? − Michael R. Clark, MD, MPH, MBA

Pain Diagnostic Methods – David M. Glick, DC, DAPPM, FASPE, CPE

Teaching the 5 Pain Coping Skills – Ted W. Jones, PhD, CPE

Pain Terminology: Knowing the Difference Makes a Difference! – Mary Lynn McPherson, PharmD, BCPS, CPE

Instructions for Participation and Credit

This activity is eligible for credit through October 15, 2014. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.

Faculty Biographies

Jennifer Bolen, JD
Founder, The Legal Side of Pain and The Pain Lawyer™
A Division of the J. Bolen Group, LLC
Knoxville, Tennessee

Ms. Jennifer Bolen owns and operates The Legal Side of Pain®, a medico-legal consulting firm specializing in the development and implementation of regulatory compliance programs and patient risk management protocols for the use of controlled substances to treat pain and the office-based treatment of opioid addiction. She conducts compliance audits, chart reviews, practice evaluations, and designs compliance materials for her clients nationwide. Ms. Bolen also serves as an expert legal consultant to defense counsel involved in administrative, civil, and criminal litigation. She reviews medical charts, helps legal counsel select medical experts, and assembles a litigation strategy to challenge opposing experts. She testifies on behalf of physicians concerning pain policy and regulations, and is qualified in court as a nationally recognized expert in this area. Ms. Bolen is responsible for the development of the Prescriber’s PROOF™ System, which is a documentation toolkit designed to help clinicians meet federal and state regulatory requirements for controlled substance prescribing.

In January 2006, the American Academy of Pain Medicine appointed Ms. Bolen to serve as Special Counsel to Academy Members. She is the legal editor for Pain Medicine News, she serves on the editorial board for and publishes in Pain Medicine, and she also publishes in The Journal of Opioid Management and Practical Pain Management. Ms. Bolen serves as guest faculty with the University of Florida’s College of Pharmacy, and co-teaches a course on Federal Regulation of Controlled Substances.

Commander John Burke
President – National Association of Drug Diversion Investigators
Owner & President – Pharmaceutical Diversion Education Inc.
Warren County Drug Task Force
Lebanon, Ohio

Commander John Burke was with the Cincinnati Police Division for 32 years and is now the Commander of the Warren County Ohio Drug Task Force. He formed the Police Division’s Pharmaceutical Diversion Squad (PDS) in 1990 and commanded that unit until October 1999 when he retired to help address the drug problems of a neighboring county. The PDS was considered by many to be the top pharmaceutical diversion unit in the United States. Law enforcement officers from across the country have trained under the guidance of his investigators. The PDS was featured on NBC’s Dateline for their efforts in the pursuit of health care professionals involved in the illegal diversion of pharmaceutical drugs from health care facilities. The segment highlighted the tremendous success made by the squad in identifying and combating drug diversion in hospitals, nursing homes, and home health care.

Commander Burke currently oversees the Warren County Drug Task Force and the Southwest Ohio High Intensity Drug Trafficking Area (HIDTA). This task force employees 17 individuals representing federal (FBI, DEA, ATF), state (BCI), Ohio National Guard, and local law enforcement agencies that come together to pursue mid to upper level drug traffickers throughout the United States.

Commander Burke has conducted hundreds of presentations on the subject of pharmaceutical diversion. He has the ability to help a wide array of attendees identify the problems, find the solutions, and institute a preventative program. The message is conveyed in a simple, common sense manner, satisfying the needs of the particular audience being addressed. The utilization of a variety of audio visuals with touches of humor makes the presentations interesting and enjoyable.

Commander Burke has written numerous articles that have been seen in health professional, law enforcement, and human resource publications across the country. He is the author of a monthly column that appears in Pharmacy Times magazine, and the editor of Rxnews, an Internet list server dealing with issues of prescription drug abuse. He is the current President of the National Association of Drug Diversion Investigators.

Michael R. Clark, MD, MPH, MBA
Associate Professor
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Dr. Michael Clark received his medical degree from Washington University School of Medicine in St. Louis, and his MPH from the Department of Epidemiology at the University of Washington School of Public Health in Seattle. He completed his internship and residency in psychiatry and behavioral sciences at The Johns Hopkins Medical Institutions and his fellowship in consultation-liaison psychiatry at the University of Washington School of Medicine. Dr. Clark is an associate professor at The Johns Hopkins University School of Medicine in Baltimore. He is the director of the Adolf Meyer Chronic Pain Treatment Programs in the Department of Psychiatry & Behavioral Sciences and has joint appointments in the Department of Otolaryngology–Head & Neck Surgery in the School of Medicine and in the Department of Mental Health in the Bloomberg School of Public Health. In addition, Dr. Clark is the medical director for Global Services with Johns Hopkins Medicine International overseeing the medical programming and key performance indicators for affiliated institutions around the world.

A fellow of the Academy of Psychosomatic Medicine, Dr. Clark currently devotes his research work to psychiatric aspects of somatic symptoms such as chronic pain, including studies on neuropathic pain, substance abuse, and the phenomenology of depression in patients with chronic pain. He serves on the National Institutes of Health Division of Research Grants Risk Prevention and Health Behavior Study Section. He has consulted as an expert for the US Department of Defense in the design of the Gulf War Specialized Health Care Centers.

David M. Glick, DC, DAPPM, FASPE, CPE
Managing Director
Pain Rx and Neural Pain Assessment
Midlothian, Virginia

Dr. David Glick currently serves as the managing director for PainRx, and Neural Pain Assessment. He has been a frontline clinician in the field of pain management for over 20 years. Dr. Glick has long focused his practice of the evaluation of difficult, chronic, and more complex cases, especially conditions related to the spine.

Dr. Glick is credentialed in the field of pain as a Diplomate of the American Academy of Pain Management and as an ASPE Certified Pain Educator. He currently serves on the Board of Directors for the American Society of Pain Educators (ASPE) and served on the committee responsible for the development of the Certified Pain Educator examination. He has been a faculty member for ASPE Pain Educators Forums as well as the PAINWeek National Conferences. As a member of the Board of Advisors for the American Academy of Pain Management, Dr. Glick served on the education planning credentialing and examination committees. He is a well-received speaker, both locally and nationally, with a focus to educating others to improve differential diagnosis and clinical management of a variety of neuropathic and musculoskeletal pain syndromes such as post-operative back and neck pain. Dr. Glick is a contributing author and section editor of the Common Pain Syndromes section for Weiner’s Pain Management, sixth edition.

Ted W. Jones, PhD, CPE
Clinical Psychologist
Behavioral Medicine Institute
Knoxville, Tennessee

Dr. Ted Jones received his PhD in clinical psychology from the University of Tennessee, Knoxville. He is a clinical psychologist with Behavioral Medicine Institute and works exclusively on-site at Pain Consultants of East Tennessee. Dr. Jones has 30 years of clinical experience, including working the last 15 years in the area of chronic pain. In addition to his full-time clinical practice, he has published multiple empirical studies, mostly on the topic of opioid risk assessment.

Dr. Jones is the president of the Pain Education Institute, a non-profit pain educational business. He is the current president of the Tennessee Pain Society and is on the Governor’s Chronic Pain Guidelines task force. The American Society of Pain Educators recognized Dr. Jones in 2013 as Clinical Pain Educator of the Year.

Mary Lynn McPherson, PharmD, BCPS, CPE
Professor and Vice Chair
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Baltimore, Maryland

Dr. Mary Lynn McPherson received her doctor of pharmacy degree from the University of Maryland School of Pharmacy. She is professor and vice chair in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, and the director of Pharmacotherapy Services at University Care Waxter in Baltimore. Dr. McPherson has maintained a practice in both hospice (local and national) and ambulatory care her entire career. She teaches extensively in the PharmD curriculum on pain management and end-of-life care, including didactic and experiential content, and she also developed one of the first and few palliative care pharmacy residencies in the US.

Dr. McPherson serves on the Board of Directors of the Hospice Network of Maryland and is Chairman of the Board of the American Society of Pain Educators. She is a fellow in the American Society of Health-Systems Pharmacists and the American Pharmacists Association. Dr. McPherson has received the American Pharmacists Association Distinguished Achievement Award in Specialized Practice, the Maryland Pharmacists Association Innovative Practice Award, and the Maryland Society of Health-Systems Pharmacists W. Purdum Lifetime Achievement Award, among others. She has written four books, and many book chapters and peer-reviewed articles on pain management, palliative care, and other topics.


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-13-374-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 13-374-336


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosures

Jennifer Bolen has received consultant fees from Alere Toxicology, AFTS Laboratories, Quest Laboratories, as well as honoraria related to speakers’ bureau activities from Quest Laboratories, and Peace Health Laboratories.

Dr. Ted Jones has received honoraria related to speakers’ bureau activities PainWeekEnd and Alere. He has received grant support related to research activities from Ethos Laboratories and AFTS Labs.

Dr. Michael Clark has received consultant fees from Eli Lilly and Company, Ameritox, and Quest Diagnostics.

Commander John Burke and Drs. David Glick and Mary Lynn McPherson have disclosed no relevant financial relationships.

Planning Committee Disclosures

The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Ms. Bolen, Commander Burke, and Drs. Glick, Jones, and McPherson have indicated that they do not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Clark has indicated that he does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Ms. Bolen, Commander Burke, and Drs. Clark, Glick, Jones and McPherson have indicated that they do not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.

This activity is supported by educational grants from Purdue Pharma, LP and Endo Pharmaceuticals.

©2013 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

Please Log In or Register to continue.